Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature. - Alig SK; Dreyling M; Seppi B; Aulinger B; Witkowski L; Rieger CT (European journal of haematology, 2015)